News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
12 04 2018 Nearly 80 percent of hospital executives surveyed are not at all familiar, or only somewhat familiar, with the Protecting Access to Medicare Act (PAMA) and its impact on hospitals, according to a...
-
11 28 2018 -- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGRAt a meeting with analysts and investors at its Investor Day tomorrow, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
11 28 2018 New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacityQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will build a flagship laboratory in Clifton, N.J. to enhance...
-
11 27 2018 Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern statesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical...
-
11 11 2018 The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stagesCHICAGO, Nov.11, 2018 — Developing novel approaches to understand pre-disease and health is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice...